Stephen Wayne Starling Jr, MD | |
2901 2nd Ave S, Birmingham, AL 35233-2933 | |
(205) 939-7143 | |
Not Available |
Full Name | Stephen Wayne Starling Jr |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 31 Years |
Location | 2901 2nd Ave S, Birmingham, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437191178 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 00020442 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Vincent's Birmingham | Birmingham, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of COL-172 for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.
Researchers at the University of Helsinki, Finland, suggest that cysteine containing tablets and chewing gum can be a new way for the prevention of upper digestive tract cancers.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
CDEX Inc. announces that Brigham and Women's Hospital (Boston, MA) has selected the CDEX ValiMedâ„¢ Medication Safety System as part of its Medication Safety Program.
› Verified 6 days ago
Entity Name | University Of Alabama Health Services Foundation, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of COL-172 for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.
Researchers at the University of Helsinki, Finland, suggest that cysteine containing tablets and chewing gum can be a new way for the prevention of upper digestive tract cancers.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
CDEX Inc. announces that Brigham and Women's Hospital (Boston, MA) has selected the CDEX ValiMedâ„¢ Medication Safety System as part of its Medication Safety Program.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Stephen Wayne Starling Jr, MD 255 W Michigan Ave, Jackson, MI 49201-2218 Ph: (517) 787-6440 | Stephen Wayne Starling Jr, MD 2901 2nd Ave S, Birmingham, AL 35233-2933 Ph: (205) 939-7143 |
News Archive
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of COL-172 for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.
Researchers at the University of Helsinki, Finland, suggest that cysteine containing tablets and chewing gum can be a new way for the prevention of upper digestive tract cancers.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
CDEX Inc. announces that Brigham and Women's Hospital (Boston, MA) has selected the CDEX ValiMedâ„¢ Medication Safety System as part of its Medication Safety Program.
› Verified 6 days ago
Riaz Mohammed Karukappadath, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Dr. Victor E. Mendoza, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5130 Cyrus Cir, Birmingham, AL 35242 Phone: 205-981-0414 | |
Joshua Edward Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Stacy Wade, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Bernis A Simmons, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 52 Medical Park Dr E, Suite 321, Birmingham, AL 35235 Phone: 205-838-3055 Fax: 205-838-3517 | |
George R. Wells Iii, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1201 11th Ave S, Birmingham, AL 35205 Phone: 205-930-7246 | |
Teddy W. Sartin, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1600 Carraway Blvd, Birmingham, AL 35234 Phone: 205-502-6817 Fax: 205-502-5152 |